Abstract:Stem cell derived small extracellular vesicles (sEVs) have been proved to promote neurological recovery after stroke. Recent studies demonstrate a phenomenal tissue repair ability in embryonic stem cell derived sEVs (ESC-sEVs). However, whether ESC-sEVs could protect against ischemic stroke remains unknown. Immune responses play an essential role in the pathogenesis of ischemic stroke, and modulating post-stroke immune responses ameliorates ischemia-induced brain damage. In this study, we aim to determine the therapeutic function of ESC-sEVs, specifically focusing on their role in immunomodulation after ischemic stroke. ESC-sEVs are intravenously administered after transient middle cerebral artery occlusion. ESC-sEVs significantly decrease leukocyte infiltration, inflammatory cytokine expression, neuronal death, and infarct volume and alleviate long-term neurological deficits and tissue loss after ischemic stroke. Interestingly, ESC-sEVs induce a marked increase in regulatory T cells (Tregs) after stroke. Further, ESC-sEV-afforded immunomodulatory function and neuroprotection against stroke are dependent on Tregs, as the depletion of Tregs almost completely abrogates the protective effects. Mechanistically, proteomic analysis reveals the enrichment of TGF-β, Smad2, and Smad4 proteins in ESC-sEVs, which could be delivered to activate the TGF-β/Smad pathway in CD4+ T cells and therefore induce Treg expansion. ESC-sEVs modulate neuroinflammation and protect against ischemic stroke through the expansion of Tregs, a process that is partially dependent on the activation of the TGF-β/Smad signaling pathway by the transfer of TGF-β, Smad2, and Smad4. The results suggest ESC-sEVs might be a candidate for immune modulation.The Supporting Information is available free of charge at <a class="ext-link" href="/doi/10.1021/acsnano.1c00672?goto=supporting-info">https://pubs.acs.org/doi/10.1021/acsnano.1c00672</a>.Dose–response of ESC-sEVs; long-term survival rate; gating strategy for microglia and macrophages; in vitro expansion of Tregs in splenocytes by ESC-sEVs; effect of ESC-sEVs on T cell apoptosis; CD3+CD4+ T cell isolation; infiltration of Tregs in brain 3 and 28 days after stroke; effect of ESC-sEV treatment on peripheral immune responses after stroke; efficiency of Treg depletion by anti-CD25 antibody; purity assessment of ESC-sEVs; Western blot analysis of proteinase-treated and nontreated ESC-sEVs; functional study of proteinase K-treated or nontreated ESC-sEVs (<a class="ext-link" href="/doi/suppl/10.1021/acsnano.1c00672/suppl_file/nn1c00672_si_001.pdf">PDF</a>)This article has not yet been cited by other publications.

Targeted delivery of CD163+macrophage-derived small extracellular vesicles<i> via</i> RGD peptides promote vascular regeneration and stabilization after spinal cord injury

Targeted delivery of CD163 + macrophage-derived small extracellular vesicles via RGD peptides promote vascular regeneration and stabilization after spinal cord injury

Intranasal delivery of small extracellular vesicles from specific subpopulation of mesenchymal stem cells mitigates traumatic spinal cord injury

Engineered extracellular vesicles for delivery of siRNA promoting targeted repair of traumatic spinal cord injury

Extracellular vesicles released by transforming growth factor-beta 1-preconditional mesenchymal stem cells promote recovery in mice with spinal cord injury

Small extracellular vesicles released by infused mesenchymal stromal cells target M2 macrophages and promote TGF‐β upregulation, microvascular stabilization and functional recovery in a rodent model of severe spinal cord injury

Small Extracellular Vesicles Derived from Altered Peptide Ligand‐Loaded Dendritic Cell Act as A Therapeutic Vaccine for Spinal Cord Injury Through Eliciting CD4 + T cell‐Mediated Neuroprotective Immunity

Ginsenoside Rg1 Regulates Immune Microenvironment and Neurological Recovery After Spinal Cord Injury Through MYCBP2 Delivery via Neuronal Cell‐Derived Extracellular Vesicles

Cerebrospinal Fluid-Derived Extracellular Vesicles after Spinal Cord Injury Promote Vascular Regeneration Via PI3K/AKT Signaling Pathway

Engineered extracellular vesicles derived from primary M2 macrophages with anti-inflammatory and neuroprotective properties for the treatment of spinal cord injury

Novel multi-drug delivery hydrogel using scar-homing liposomes improves spinal cord injury repair.

Targeted Delivery of RGD-CD146 + CD271 + Human Umbilical Cord Mesenchymal Stem Cell-Derived Exosomes Promotes Blood–Spinal Cord Barrier Repair after Spinal Cord Injury

Small extracellular vesicles derived from four dimensional-culture of mesenchymal stem cells induce alternatively activated macrophages by upregulating IGFBP2/EGFR to attenuate inflammation in the spinal cord injury of rats

A tannic acid doped hydrogel with small extracellular vesicles derived from mesenchymal stem cells promotes spinal cord repair by regulating reactive oxygen species microenvironment

Enhancement of motor functional recovery using immunomodulatory extracellular vesicles-loaded injectable thermosensitive hydrogel post spinal cord injury

An Injectable Recombinant Human Milk Fat Globule Epidermal Growth Factor 8 Loaded Copolymer System for Spinal Cord Injury Reduces Inflammation Through NF-B and Neuronal Cell Death

Small Extracellular Vesicles Derived from Mesenchymal Stem Cell Facilitate Functional Recovery in Spinal Cord Injury by Activating Neural Stem Cells Via the ERK1/2 Pathway

Local delivery of EGFR + NSCs-derived exosomes promotes neural regeneration post spinal cord injury via miR-34a-5p/HDAC6 pathway

Mesenchymal Stem Cell Derived EVs Mediate Neuroprotection after Spinal Cord Injury in Rats Via the Microrna-21-5p/fasl Gene Axis.

Effective treatment of optic neuropathies by intraocular delivery of MSC-sEVs through augmenting the G-CSF-macrophage pathway

Embryonic Stem Cell Derived Small Extracellular Vesicles Modulate Regulatory T Cells to Protect against Ischemic Stroke